50 related articles for article (PubMed ID: 30811306)
1. Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study.
Molife C; Winfree KB; Bailey H; D'yachkova Y; Forshaw C; Kim S; Taipale KL; Puri T
Adv Ther; 2023 Jul; 40(7):3135-3168. PubMed ID: 37221352
[TBL] [Abstract][Full Text] [Related]
2. Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.
Hofman P; Calabrese F; Kern I; Adam J; Alarcão A; Alborelli I; Anton NT; Arndt A; Avdalyan A; Barberis M; Bégueret H; Bisig B; Blons H; Boström P; Brcic L; Bubanovic G; Buisson A; Caliò A; Cannone M; Carvalho L; Caumont C; Cayre A; Chalabreysse L; Chenard MP; Conde E; Copin MC; Côté JF; D'Haene N; Dai HY; de Leval L; Delongova P; Denčić-Fekete M; Fabre A; Ferenc F; Forest F; de Fraipont F; Garcia-Martos M; Gauchotte G; Geraghty R; Guerin E; Guerrero D; Hernandez S; Hurník P; Jean-Jacques B; Kashofer K; Kazdal D; Lantuejoul S; Leonce C; Lupo A; Malapelle U; Matej R; Merlin JL; Mertz KD; Morel A; Mutka A; Normanno N; Ovidiu P; Panizo A; Papotti MG; Parobkova E; Pasello G; Pauwels P; Pelosi G; Penault-Llorca F; Picot T; Piton N; Pittaro A; Planchard G; Poté N; Radonic T; Rapa I; Rappa A; Roma C; Rot M; Sabourin JC; Salmon I; Prince SS; Scarpa A; Schuuring E; Serre I; Siozopoulou V; Sizaret D; Smojver-Ježek S; Solassol J; Steinestel K; Stojšić J; Syrykh C; Timofeev S; Troncone G; Uguen A; Valmary-Degano S; Vigier A; Volante M; Wahl SGF; Stenzinger A; Ilié M
ESMO Open; 2023 Oct; 8(5):101628. PubMed ID: 37713929
[TBL] [Abstract][Full Text] [Related]
3. Understanding Molecular Testing Uptake Across Tumor Types in Eight Countries: Results From a Multinational Cross-Sectional Survey.
Chambers P; Man KKC; Lui VWY; Mpima S; Nasuti P; Forster MD; Wong ICK
JCO Oncol Pract; 2020 Aug; 16(8):e770-e778. PubMed ID: 32160136
[TBL] [Abstract][Full Text] [Related]
4. Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada.
Grafham GK; Craddock KJ; Huang WY; Louie AV; Zhang L; Hwang DM; Parmar A
Cancer Med; 2024 Feb; 13(3):e6886. PubMed ID: 38317584
[TBL] [Abstract][Full Text] [Related]
5. Oncologist-Reported Reasons for Not Ordering Multimarker Tumor Panels: Results From a Nationally Representative Survey.
Roberts MC; Spees LP; Freedman AN; Klein WMP; Prabhu Das I; Butler EN; de Moor JS
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250411
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and prognostic contributors in patients with
Burns EA; Ensor JE; Hsu J; Thomas JS; Olsen RJ; Bernicker EH
J Thorac Dis; 2021 Aug; 13(8):4785-4796. PubMed ID: 34527319
[TBL] [Abstract][Full Text] [Related]
7. Testing for
Dalurzo ML; Avilés-Salas A; Soares FA; Hou Y; Li Y; Stroganova A; Öz B; Abdillah A; Wan H; Choi YL
Onco Targets Ther; 2021; 14():4671-4692. PubMed ID: 34511936
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients.
Roengvoraphoj M; Tsongalis GJ; Dragnev KH; Rigas JR
Cancer Treat Rev; 2013 Dec; 39(8):839-50. PubMed ID: 23768755
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation-positive non-small cell lung cancers: an update for recent advances in therapeutics.
Chung C
J Oncol Pharm Pract; 2016 Jun; 22(3):461-76. PubMed ID: 25855240
[TBL] [Abstract][Full Text] [Related]
10. Clinical Use of Epidermal Growth Factor Receptor Testing in Patients With Advanced Lung Cancer by Physicians: Survey of US and International Patterns.
Peters M; Kim ES; Hirsch V
J Glob Oncol; 2019 Feb; 5():1-7. PubMed ID: 30811306
[TBL] [Abstract][Full Text] [Related]
11. Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: An international observational study.
Subramanian J; Leighl NB; Choi YL; Chou TY; Gregg J; Hui R; Marchetti A; Silvey M; Makin R; Gillespie-Akar L; Taylor A; Kahangire DA; Bailey T; Chau M; Navani N
Lung Cancer; 2023 Jan; 175():47-56. PubMed ID: 36455396
[TBL] [Abstract][Full Text] [Related]
12. EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer.
Hung A; Lee KM; Alba PR; Li Y; Gao AZ; Hintze BJ; Efimova OV; Shenolikar R; Pavilack M; Simmons D; Kelley MJ; Lynch JA; Reed SD
Cancer Treat Res Commun; 2021; 27():100327. PubMed ID: 33549984
[TBL] [Abstract][Full Text] [Related]
13. Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study.
Lee DH; Tsao MS; Kambartel KO; Isobe H; Huang MS; Barrios CH; Khattak A; de Marinis F; Kothari S; Arunachalam A; Cao X; Burke T; Valladares A; de Castro J
PLoS One; 2018; 13(8):e0202865. PubMed ID: 30148862
[TBL] [Abstract][Full Text] [Related]
14.
Palacio S; Pontes L; Prado E; Arshad J; Ali R; Piha T; Bacchi CE; Mudad R; Lopes G
Oncologist; 2019 Apr; 24(4):e137-e141. PubMed ID: 30446583
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
